Houqun Ying

11PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 29, 2026
OTUD6B-mediated K48 deubiquitination of FXR1 forms a positive feedback loop activating MEK2/ERK signaling in colorectal cancer liver metastasis.

|Jan 12, 2026
Cancer-derived inflammation is associated with bevacizumab resistance and inferior clinical outcomes in patients with metastatic colorectal cancer.

Ya-Nan Li, Yang Wu, Feng-Wen Deng

|Jan 08, 2026
CCT3 Facilitates the Malignant Progression of NSCLC and SCLC via PI3 K/AKT-EMT Axis and Emerges as a Novel Serum Diagnostic Biomarker.

Guobin Song, Kexin Han, Lin Xiang

|Oct 29, 2025
Chronic Inflammatory Comprehensive Signature Predicts Oxaliplatin and 5-Fluorouracil Benefit in Early Colorectal Cancer.

Yue Peng, Rong Shang, Zhi-Jie Wang

|Mar 20, 2025
Robust Predictive Performance of MLPAS and CCMLP for Clinical Outcome and Risk Stratification in Patients with Colorectal Cancer.

Qiu-Ying Ye, Yuan-Yuan Wang, Zhi-Jie Wang

|Oct 09, 2023
Clinical Significance of Fibrinogen and Platelet to Pre-Albumin Ratio in Predicting the Prognosis of Advanced Gastric Cancer.

Huakai Tian, Zitao Liu, Zuo Zhang

Pageof 2

Frequent Collaborators

5 joint publications

Xue-Xin Cheng

2 joint publications

Ying Lu

2 joint publications

Guobin Song

2 joint publications

Lin Xiang